Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways

Hematology/Oncology Clinics of North America

Volumn 18, Issue 5, 2004, Pages 1039-1057

  Wachsberger, Phyllis ^a   Burd, Randy ^a   Dicker, Adam P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; BEVACIZUMAB; FUMAGILLOL CHLOROACETYLCARBAMATE; HYPOXIA INDUCIBLE FACTOR 1; MONOCLONAL ANTIBODY DC101; TNP 40; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; CANCER; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESISTANCE; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANIMALS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 5044223266     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2004.06.007     Document Type: Review

References (93)

1. F. Dal Pizzol, C. Ritter, F. Klamt, M. Andrades, M.L. da Frota Jr, and C. Diel Modulation of oxidative stress in response to gamma-radiation in human glioma cell lines J Neurooncol 61 2 2003 89 94
2. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 21 1971 1182 1186
3. J. Marx Angiogenesis. A boost for tumor starvation Science 301 5632 2003 452 454
4. J.C. Yang, L. Haworth, R.M. Sherry, P. Hwu, D.J. Schwartzentruber, and S.L. Topalian A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer N Engl J Med 349 5 2003 427 434
5. R. Kerbel, and J. Folkman Clinical translation of angiogenesis inhibitors Nat Rev Cancer 2 10 2002 727 739
6. D.H. Gorski, H.J. Mauceri, R.M. Salloum, S. Gately, S. Hellman, and M.A. Beckett Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin Cancer Res 58 24 1998 5686 5689
7. D.H. Gorski, M.A. Beckett, N.T. Jaskowiak, D.P. Calvin, H.J. Mauceri, and R.M. Salloum Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation Cancer Res 59 14 1999 3374 3378
8. H.J. Mauceri, N.N. Hanna, J.D. Wayne, D.E. Hallahan, S. Hellman, and R.R. Weichselbaum Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature Cancer Res 56 19 1996 4311 4314
9. H.J. Mauceri, N.N. Hanna, M.A. Beckett, D.H. Gorski, M.J. Staba, and K.A. Stellato Combined effects of angiostatin and ionizing radiation in antitumour therapy Nature 394 6690 1998 287 291
10. C.G. Lee, M. Heijn, E. di Tomaso, G. Griffon-Etienne, M. Ancukiewicz, and C. Koike Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res 60 19 2000 5565 5570
11. C.Y. Li, S. Shan, Q. Huang, R.D. Braun, J. Lanzen, and K. Hu Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models J Natl Cancer Inst 92 2 2000 143 147
12. L. Holmgren, M.S. O'Reilly, and J. Folkman Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat Med 1 2 1995 149 153
13. J. Folkman The role of angiogenesis in tumor growth Semin Cancer Biol 3 2 1992 65 71
14. P. Wachsberger, R. Burd, and A.P. Dicker Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction Clin Cancer Res 9 6 2003 1957 1971
15. A. Lal, H. Peters, B. St Croix, Z.A. Haroon, M.W. Dewhirst, and R.L. Strausberg Transcriptional response to hypoxia in human tumors J Natl Cancer Inst 93 17 2001 1337 1343
16. B.B. Ma, R.G. Bristow, J. Kim, and L.L. Siu Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents J Clin Oncol 21 14 2003 2760 2776
17. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res 49 23 1989 6449 6465
18. J. Rak, J.L. Yu, R.S. Kerbel, and B.L. Coomber What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors? Cancer Res 62 7 2002 1931 1934
19. A.L. Kung, S. Wang, J.M. Klco, W.G. Kaelin, and D.M. Livingston Suppression of tumor growth through disruption of hypoxia-inducible transcription Nat Med 6 12 2000 1335 1340
20. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 6398 1992 843 845
21. G.L. Wang, B.H. Jiang, E.A. Rue, and G.L. Semenza Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension Proc Natl Acad Sci U S A 92 12 1995 5510 5514
22. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 10 2003 721 732
23. B. Krishnamachary, S. Berg-Dixon, B. Kelly, F. Agani, D. Feldser, and G. Ferreira Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1 Cancer Res 63 5 2003 1138 1143
24. R. Fukuda, K. Hirota, F. Fan, Y.D. Jung, L.M. Ellis, and G.L. Semenza Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells J Biol Chem 277 41 2002 38205 38211
25. R. Fukuda, B. Kelly, and G.L. Semenza Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E(2) is mediated by hypoxia-inducible factor 1 Cancer Res 63 9 2003 2330 2334
26. A. Maity, N. Pore, J. Lee, D. Solomon, and D.M. O'Rourke Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia Cancer Res 60 20 2000 5879 5886
27. D. Fukumura, R. Xavier, T. Sugiura, Y. Chen, E.C. Park, and N. Lu Tumor induction of VEGF promoter activity in stromal cells Cell 94 6 1998 715 725
28. P. Dent, A. Yacoub, J. Contessa, R. Caron, G. Amorino, and K. Valerie Stress and radiation-induced activation of multiple intracellular signaling pathways Radiat Res 159 3 2003 283 300
29. E. Minet, T. Arnould, G. Michel, I. Roland, D. Mottet, and M. Raes ERK activation upon hypoxia: involvement in HIF-1 activation FEBS Lett 468 1 2000 53 58
30. C. Treins, S. Giorgetti-Peraldi, J. Murdaca, G.L. Semenza, and E. Van Obberghen Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway J Biol Chem 277 31 2002 27975 27981
31. G. Semenza Signal transduction to hypoxia-inducible factor 1 Biochem Pharmacol 64 5-6 2002 993 998
32. J. Mateo, M. Garcia-Lecea, S. Cadenas, C. Hernandez, and S. Moncada Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways Biochem J 376 Pt 2 2003 537 544
33. V.V. Sumbayev, A. Budde, J. Zhou, and B. Brune HIF-1 alpha protein as a target for S-nitrosation FEBS Lett 535 1-3 2003 106 112
34. Y.J. Jung, J.S. Isaacs, S. Lee, J. Trepel, and L. Neckers IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J 17 14 2003 2115 2117
35. X.H. Liu, A. Kirschenbaum, M. Lu, S. Yao, A. Dosoretz, and J.F. Holland Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line J Biol Chem 277 51 2002 50081 50086
36. G. Eibl, D. Bruemmer, Y. Okada, J.P. Duffy, R.E. Law, and H.A. Reber PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells Biochem Biophys Res Commun 306 4 2003 887 897
37. T. Kuwano, S. Nakao, H. Yamamoto, M. Tsuneyoshi, T. Yamamoto, and M. Kuwano Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis FASEB J 18 2 2004 300 310
38. J.K. Leach, S.M. Black, R.K. Schmidt-Ullrich, and R.B. Mikkelsen Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation J Biol Chem 277 18 2002 15400 15406
39. K.B. Sandau, H.G. Faus, and B. Brune Induction of hypoxia-inducible- factor 1 by nitric oxide is mediated via the PI 3K pathway Biochem Biophys Res Commun 278 1 2000 263 267
40. M.I. Koukourakis, A. Giatromanolaki, E. Sivridis, K. Simopoulos, G. Pissakas, and K.C. Gatter Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy Anticancer Res 21 6B 2001 4301 4309
41. S. Lanza-Jacoby, A. Dicker, S. Miller, F. Rosato, J.T. Flynn, and S. Lavorgna Cyclooxygenase (COX)-2 dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice Mol Cancer Ther 3 4 2004 417 424
42. B.A. Teicher, S.A. Holden, G. Ara, N.P. Dupuis, F. Liu, and J. Yuan Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy Int J Cancer 61 5 1995 732 737
43. R. Murata, Y. Nishimura, and M. Hiraoka An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma Int J Radiat Oncol Biol Phys 37 1997 1107 1113
44. E.L. Lund, L. Bastholm, and P.E. Kristjansen Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts Clin Cancer Res 6 2000 971 978
45. F. Griscelli, H. Li, and C. Cheong Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model Proc Natl Acad Sci U S A 97 2000 6698 6703
46. H.J. Mauceri, N.N. Hanna, and M.A. Beckett Combined effects of angiostatin and ionizing radiation in antitumour therapy Nature 394 1998 287 291
47. S.V. Kozin, Y. Boucher, D.J. Hicklin, P. Bohlen, R.K. Jain, and H.D. Suit Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts Cancer Res 61 2001 39 44
48. L. Geng, E. Donnelly, and G. McMahon Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy Cancer Res 61 2001 2413 2419
49. R.J. Griffin, B.W. Williams, R. Wild, J.M. Cherrington, H. Park, and C.W. Song Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response Cancer Res 62 2002 1702 1706
50. C. Hess, V. Vuong, and I. Hegyi Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth Br J Cancer 85 2001 2010 2016
51. D.H. Gorski, M.A. Beckett, and N.T. Jaskowiak Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation Cancer Res 59 1999 3374 3378
52. C.G. Lee, M. Heijn, and E. di Tomaso Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res 60 2000 5565 5570
53. L. Geng, E. Donnelly, G. McMahon, P.C. Lin, E. Sierra-Rivera, and H. Oshinka Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy Cancer Res 61 6 2001 2413 2419
54. R.J. Griffin, B.W. Williams, R. Wild, J.M. Cherrington, H. Park, and C.W. Song Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response Cancer Res 62 6 2002 1702 1706
55. S.V. Kozin, Y. Boucher, D.J. Hicklin, P. Bohlen, R.K. Jain, and H.D. Suit Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts Cancer Res 61 1 2001 39 44
56. E.L. Lund, L. Bastholm, and P.E. Kristjansen Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts Clin Cancer Res 6 3 2000 971 978
57. B.A. Teicher, Y. Emi, Y. Kakeji, and D. Northey TNP-470/minocycline/ cytotoxic therapy: a systems approach to cancer therapy Eur J Cancer 32A 14 1996 2461 2466
58. J. Folkman, and K. Camphausen Cancer. What does radiotherapy do to endothelial cells? Science 293 5528 2001 227 228
59. V.K. Gupta, N.T. Jaskowiak, M.A. Beckett, H.J. Mauceri, J. Grunstein, and R.S. Johnson Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance Cancer J 8 1 2002 47 54
60. M.S. O'Reilly, L. Holmgren, C. Chen, and J. Folkman Angiostatin induces and sustains dormancy of human primary tumors in mice Nat Med 2 6 1996 689 692
61. B.A. Teicher, S.A. Holden, N.P. Dupuis, Y. Kakeji, M. Ikebe, and Y. Emi Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma Breast Cancer Res Treat 36 2 1995 227 236
62. R.M. Shaheen, W.W. Tseng, D.W. Davis, W. Liu, N. Reinmuth, and R. Vellagas Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms Cancer Res 61 4 2001 1464 1468
63. A.J. Schueneman, E. Himmelfarb, L. Geng, J. Tan, E. Donnelly, and D. Mendel SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models Cancer Res 63 14 2003 4009 4016
64. N. Reinmuth, O. Stoeltzing, W. Liu, S.A. Ahmad, Y.D. Jung, and F. Fan Endothelial survival factors as targets for antineoplastic therapy Cancer J 7 Suppl 3 2001 S109 S119
65. J. Holash, S. Davis, N. Papadopoulos, S.D. Croll, L. Ho, and M. Russell VEGF-Trap: a VEGF blocker with potent antitumor effects Proc Natl Acad Sci U S A 99 17 2002 11393 11398
66. Wachsberger PR, Burd R, Marrero N, Workman J, Holash J, Yancopoulos GD, et al. Improvement of tumor control by combining a VEGF blocker, VEGF Trap with radiation therapy [abstract]. Presented at the International Conference of the American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer on Molecular Targets and Cancer Therapeutics, Boston, November 17-21, 2003
67. S. Gately The contributions of cyclooxygenase-2 to tumor angiogenesis Cancer Metastasis Rev 19 1-2 2000 19 27
68. O. Gallo, A. Franchi, L. Magnelli, I. Sardi, A. Vannacci, and V. Boddi Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis Neoplasia 3 1 2001 53 61
69. H.S. Kim, H.R. Youm, J.S. Lee, K.W. Min, J.H. Chung, and C.S. Park Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer Lung Cancer 42 2 2003 163 170
70. K. Uefuji, T. Ichikura, and H. Mochizuki Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer Clin Cancer Res 6 1 2000 135 138
71. T.W. Davis, J.M. O'Neal, M.D. Pagel, B.S. Zweifel, P.P. Mehta, and D.M. Heuvelman Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature Cancer Res 64 1 2004 279 285
72. S. Kyrkanides, A.H. Moore, J.A. Olschowka, J.C. Daeschner, J.P. Williams, and J.T. Hansen Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury Brain Res Mol Brain Res 104 2 2002 159 169
73. U. Raju, E. Nakata, P. Yang, R.A. Newman, K.K. Ang, and L. Milas In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations Int J Radiat Oncol Biol Phys 54 3 2002 886 894
74. K.K. Steinauer, I. Gibbs, S. Ning, J.N. French, J. Armstrong, and S.J. Knox Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells Int J Radiat Oncol Biol Phys 48 2 2000 325 328
75. E.L. Lund, A. Hog, M.W. Olsen, L.T. Hansen, S.A. Engelholm, and P.E. Kristjansen Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma Int J Cancer 108 6 2004 833 838
76. S. Yoshida, H. Amano, I. Hayashi, H. Kitasato, M. Kamata, and M. Inukai COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo Lab Invest 83 10 2003 1385 1394
77. C. Petersen, S. Petersen, L. Milas, F.F. Lang, and P.J. Tofilon Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor Clin Cancer Res 6 6 2000 2513 2520
78. L. Milas, T. Akimoto, N.R. Hunter, K.A. Mason, L. Buchmiller, and M. Yamakawa Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas Int J Radiat Oncol Biol Phys 52 2 2002 514 521
79. H. Pyo, H. Choy, G.P. Amorino, J.S. Kim, Q. Cao, and S.K. Hercules A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2 Clin Cancer Res 7 10 2001 2998 3005
80. A.P. Dicker, T.L. Williams, and D.S. Grant Targeting angiogenic processes by combination rofecoxib and ionizing radiation Am J Clin Oncol 24 5 2001 438 442
81. S.T. Palayoor, P.J. Tofilon, and C.N. Coleman Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells Clin Cancer Res 9 8 2003 3150 3157
82. A. Abdollahi, K.E. Lipson, X. Han, R. Krempien, T. Trinh, and K.J. Weber SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro Cancer Res 63 13 2003 3755 3763
83. F. Paris, Z. Fuks, A. Kang, P. Capodieci, G. Juan, and D. Ehleiter Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice Science 293 5528 2001 293 297
84. L.A. Pena, Z. Fuks, and R.N. Kolesnick Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency Cancer Res 60 2 2000 321 327
85. J.G. Maj, F. Paris, A. Haimovitz-Friedman, E. Venkatraman, R. Kolesnick, and Z. Fuks Microvascular function regulates intestinal crypt response to radiation Cancer Res 63 15 2003 4338 4341
86. M. Garcia-Barros, F. Paris, C. Cordon-Cardo, D. Lyden, S. Rafii, and A. Haimovitz-Friedman Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 300 5622 2003 1155 1159
87. E.J. Hall Radiobiology for the radiologist 5th edition 2000 Lippincott Williams & Wilkins Philadelphia
88. D.M. Aebersold, P. Burri, K.T. Beer, J. Laissue, V. Djonov, and R.H. Greiner Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer Cancer Res 61 7 2001 2911 2916
89. A. Unruh, A. Ressel, H.G. Mohamed, R.S. Johnson, R. Nadrowitz, and E. Richter The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy Oncogene 22 21 2003 3213 3220
90. S.M. Huang, J. Li, E.A. Armstrong, and P.M. Harari Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa) Cancer Res 62 15 2002 4300 4306
91. Dicker AP, Anne R, Bonanni R, Sidor C, Gubish E, Curran Jr WJ. Phase I trial results of recombinant human angiostatin protein (rhA) and external beam radiation therapy (EBRT). Presented at the 38th Annual Meeting of the American Association of Clinical Oncology. Orlando (Florida), May 17-21, 2002
92. C.G. Willett, Y. Boucher, E. di Tomaso, D.G. Duda, L.L. Munn, and R.T. Tong Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nat Med 10 2 2004 145 147
93. M. Relf, S. Lejeune, P.A. Scott, S. Fox, K. Smith, and R. Leek Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis Cancer Res 57 5 1997 963 969